Mukul Agrawal-Backed Stock Hits Upper Circuit; Gains Around Rs 1,34,25,000 In A Single Day

Indian equity markets ended higher on Tuesday, with the benchmark Nifty 50 index rising 0.17 per cent to 23,659.00. In the broader market, shares of Gaudium IVF and Women Health gained 4.99 per cent to Rs 112.93 and hit Upper Circuit amid investor interest in the stock.

Shareholding and Stock Performance

As per the latest shareholding pattern for the quarter ended March 2026, promoters held 71.29 per cent stake in the company, while FIIs and DIIs held 6.70 per cent and 2.63 per cent stake, respectively. Investor Mukul Mahavir Agrawal owned 25,00,000 equity shares representing 3.43 per cent stake in the company during the quarter.

Public shareholding in the company stood at 19.39 per cent as of March 2026. Other public shareholders included GDN Investments Pvt Ltd with 2.75 per cent stake and Kishan Gopal Mohta with 1.27 per cent stake.

The stock has delivered strong short-term performance, rising around 17.71 per cent over the past one month. However, the stock remains down nearly 40.71 per cent over the past six months. The company currently commands a market capitalisation of around Rs 819 crore.

Recent Company Update

Recently, Gaudium IVF informed exchanges that Infomerics Valuation and Rating Limited submitted its Monitoring Agency Report for the quarter ended March 31, 2026, in relation to the utilisation of IPO proceeds. The report stated that there were no deviations in the utilisation of issue proceeds from the objects mentioned in the offer document.

The company had raised Rs 90 crore through its IPO and plans to utilise Rs 50 crore towards establishment of new IVF centres, Rs 20 crore towards repayment or pre-payment of borrowings, and Rs 12.28 crore towards general corporate purposes.

About Gaudium IVF

Gaudium IVF and Women Health Ltd is an Indian fertility and women healthcare company focused on IVF and assisted reproductive treatment services. The company operates through a hub-and-spoke business model and has presence across multiple states in India.

The company currently operates more than 30 locations, including IVF centres and strategic alliance-based spoke centres. As part of its expansion plans, the company intends to establish 19 new IVF centres across India between FY27 and FY29 using IPO proceeds.

What are your views on Gaudium IVF’s expansion plans and the recent movement in the stock? Share your thoughts in the comments below.
Disclaimer: This article is for informational purposes only and not investment advice.